A decade of developments in chronic heart failure treatment: A comparison of therapy and outcome in a secondary and tertiary hospital setting

Clinical Research in Cardiology

Volumn 101, Issue 1, 2012, Pages 1-10

  Franke, Jennifer ^a   Zugck, Christian ^a   Wolter, Jan Sebastian ^a   Frankenstein, Lutz ^a   Hochadel, Matthias ^a   Ehlermann, Philipp ^a   Winkler, Ralph ^b   Nelles, Manfred ^a   Zahn, Ralf ^b   Katus, Hugo A ^a   Senges, Jochen ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Heart Center Ludwigshafen   (Germany)

Author keywords

Dilated cardiomyopathy; Heart failure; Ischaemic cardiomyopathy; Secondary hospital setting; Tertiary hospital setting

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COMPARATIVE STUDY; CONGESTIVE CARDIOMYOPATHY; DEVICE THERAPY; FEMALE; FOLLOW UP; HEART TRANSPLANTATION; HUMAN; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRACTICE GUIDELINE; SURVIVAL RATE; SYSTOLIC HEART FAILURE; TERTIARY HEALTH CARE;

AGE FACTORS; AGED; CARDIOMYOPATHIES; CARDIOMYOPATHY, DILATED; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; GERMANY; GUIDELINE ADHERENCE; HEART FAILURE; HEART TRANSPLANTATION; HOSPITALS, SPECIAL; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84856283222     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-011-0348-6     Document Type: Article

References (24)

1. K Dickstein A Cohen-Solal G Filippatos JJ McMurray P Ponikowski PA Poole-Wilson A Stromberg DJ van Veldhuisen D Atar AW Hoes A Keren A Mebazaa M Nieminen SG Priori K Swedberg A Vahanian J Camm R De Caterina V Dean C Funck-Brentano I Hellemans SD Kristensen K McGregor U Sechtem S Silber M Tendera P Widimsky JL Zamorano 2008 Esc guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the european society of cardiology. Developed in collaboration with the heart failure association of the esc (hfa) and endorsed by the european society of intensive care medicine (esicm) Eur Heart J 29 19 2388 2442 10.1093/eurheartj/ehn309 18799522 10.1093/eurheartj/ehn309 1:CAS:528:DC%2BD1cXhtlGisbvO
2. K Swedberg J Cleland H Dargie H Drexler F Follath M Komajda L Tavazzi OA Smiseth A Gavazzi A Haverich A Hoes T Jaarsma J Korewicki S Levy C Linde JL Lopez-Sendon MS Nieminen L Pierard WJ Remme 2005 Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the task force for the diagnosis and treatment of chronic heart failure of the european society of cardiology Eur Heart J 26 11 1115 1140 10.1093/eurheartj/ ehi204 15901669 10.1093/eurheartj/ehi204 (Pubitemid 40839912)
3. SA Hunt DW Baker MH Chin MP Cinquegrani AM Feldman GS Francis TG Ganiats S Goldstein G Gregoratos ML Jessup RJ Noble M Packer MA Silver LW Stevenson RJ Gibbons EM Antman JS Alpert DP Faxon V Fuster AK Jacobs LF Hiratzka RO Russell SC Smith Jr 2001 Acc/aha guidelines for the evaluation and management of chronic heart failure in the adult: executive summary a report of the american college of cardiology/american heart association task force on practice guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure): developed in collaboration with the international society for heart and lung transplantation; endorsed by the heart failure society of america Circulation 104 24 2996 3007 11739319 10.1161/hc4901.102568 1:STN:280:DC%2BD3MnptFejug%3D%3D (Pubitemid 33139116)
4. SA Hunt WT Abraham MH Chin AM Feldman GS Francis TG Ganiats M Jessup MA Konstam DM Mancini K Michl JA Oates PS Rahko MA Silver LW Stevenson CW Yancy EM Antman SC Smith Jr CD Adams JL Anderson DP Faxon V Fuster JL Halperin LF Hiratzka AK Jacobs R Nishimura JP Ornato RL Page B Riegel 2005 Acc/aha 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the american college of cardiology/american heart association task force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure): developed in collaboration with the american college of chest physicians and the international society for heart and lung transplantation: endorsed by the heart rhythm society Circulation 112 12 e154 e235 10.1161/CIRCULATIONAHA.105.167586 16160202 10.1161/CIRCULATIONAHA.105.167586
5. SA Hunt WT Abraham MH Chin AM Feldman GS Francis TG Ganiats M Jessup MA Konstam DM Mancini K Michl JA Oates PS Rahko MA Silver LW Stevenson CW Yancy 2009 2009 Focused update incorporated into the acc/aha 2005 guidelines for the diagnosis and management of heart failure in adults a report of the american college of cardiology foundation/american heart association task force on practice guidelines developed in collaboration with the international society for heart and lung transplantation J Am Coll Cardiol 53 15 e1 e90 10.1016/j.jacc.2008.11.013 19358937 10.1016/j.jacc.2008.11.013
6. JG Cleland A Cohen-Solal JC Aguilar R Dietz J Eastaugh F Follath N Freemantle A Gavazzi WH van Gilst FD Hobbs J Korewicki HC Madeira I Preda K Swedberg J Widimsky 2002 Management of heart failure in primary care (the improvement of heart failure programme): an international survey Lancet 360 9346 1631 1639 12457785 10.1016/S0140-6736(02)11601-1 1:STN:280: DC%2BD38nps12gsA%3D%3D (Pubitemid 35379734)
7. JG Cleland K Swedberg F Follath M Komajda A Cohen-Solal JC Aguilar R Dietz A Gavazzi R Hobbs J Korewicki HC Madeira VS Moiseyev I Preda WH van Gilst J Widimsky N Freemantle J Eastaugh J Mason 2003 The euroheart failure survey programme-a survey on the quality of care among patients with heart failure in europe. Part 1: patient characteristics and diagnosis Eur Heart J 24 5 442 463 12633546 10.1016/S0195-668X(02)00823-0 1:STN:280:DC%2BD3s7itVWjug%3D%3D (Pubitemid 36286187)
8. VL Roger SA Weston MM Redfield JP Hellermann-Homan J Killian BP Yawn SJ Jacobsen 2004 Trends in heart failure incidence and survival in a community-based population JAMA 292 3 344 350 15265849 10.1001/jama.292.3.344 1:CAS:528:DC%2BD2cXlvFaju7k%3D (Pubitemid 38944258)
9. D Levy S Kenchaiah MG Larson EJ Benjamin MJ Kupka KK Ho JM Murabito RS Vasan 2002 Long-term trends in the incidence of and survival with heart failure N Engl J Med 347 18 1397 1402 12409541 10.1056/NEJMoa020265 (Pubitemid 35239711)
10. M Senni CM Tribouilloy RJ Rodeheffer SJ Jacobsen JM Evans KR Bailey MM Redfield 1999 Congestive heart failure in the community: trends in incidence and survival in a 10-year period Arch Intern Med 159 1 29 34 9892327 10.1001/archinte.159.1.29 1:STN:280:DyaK1M7gslentw%3D%3D (Pubitemid 29044116)
11. DM Henkel MM Redfield SA Weston Y Gerber VL Roger 2008 Death in heart failure: a community perspective Circ Heart Fail 1 2 91 97 10.1161/ CIRCHEARTFAILURE.107.743146 19300532 10.1161/CIRCHEARTFAILURE.107.743146
12. P Richardson W McKenna M Bristow B Maisch B Mautner J O'Connell E Olsen G Thiene J Goodwin I Gyarfas I Martin P Nordet 1996 Report of the 1995 world health organization/international society and federation of cardiology task force on the definition and classification of cardiomyopathies Circulation 93 5 841 842 8598070 10.1161/01.CIR.93.5.841 1:STN:280:DyaK287nvFSisg%3D%3D (Pubitemid 26074816)
13. B Pitt F Zannad WJ Remme R Cody A Castaigne A Perez J Palensky J Wittes 1999 The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators N Engl J Med 341 10 709 717 10.1056/NEJM199909023411001 10471456 10.1056/ NEJM199909023411001 1:CAS:528:DyaK1MXmtVyrurk%3D (Pubitemid 29407370)
14. AJ Moss W Zareba WJ Hall H Klein DJ Wilber DS Cannom JP Daubert SL Higgins MW Brown ML Andrews 2002 Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 12 877 883 11907286 10.1056/NEJMoa013474 (Pubitemid 34984635)
15. JG Cleland JC Daubert E Erdmann N Freemantle D Gras L Kappenberger L Tavazzi 2005 The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 15 1539 1549 10.1056/NEJMoa050496 15753115 10.1056/NEJMoa050496 1:CAS:528:DC%2BD2MXjtFGnsLo%3D (Pubitemid 40517094)
16. EM Hylek C Evans-Molina C Shea LE Henault S Regan 2007 Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation Circulation 115 21 2689 2696 10.1161/CIRCULATIONAHA. 106.653048 17515465 10.1161/CIRCULATIONAHA.106.653048 1:CAS:528: DC%2BD2sXlsVOns7o%3D (Pubitemid 46842784)
17. Meinertz T, Kirch W, Rosin L, Pittrow D, Willich SN, Kirchhof P (2011) Management of atrial fibrillation by primary care physicians in Germany: baseline results of the atrium registry. Clin Res Cardiol. doi: 10.1007/s00392-011-0320-5
18. M Komajda F Follath K Swedberg J Cleland JC Aguilar A Cohen-Solal R Dietz A Gavazzi WH Van Gilst R Hobbs J Korewicki HC Madeira VS Moiseyev I Preda J Widimsky N Freemantle J Eastaugh J Mason 2003 The euroheart failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment Eur Heart J 24 5 464 474 12633547 10.1016/S0195- 668X(02)00700-5 1:STN:280:DC%2BD3s7itVWjuw%3D%3D (Pubitemid 36286188)
19. A Jost B Rauch M Hochadel R Winkler S Schneider M Jacobs C Kilkowski A Kilkowski H Lorenz K Muth C Zugck A Remppis M Haass J Senges 2005 Beta-blocker treatment of chronic systolic heart failure improves prognosis even in patients meeting one or more exclusion criteria of the merit-hf study Eur Heart J 26 24 2689 2697 10.1093/eurheartj/ehi473 16183697 10.1093/eurheartj/ehi473 1:CAS:528:DC%2BD28Xnt1yrsA%3D%3D (Pubitemid 41746692)
20. GC Fonarow NM Albert AB Curtis WG Stough M Gheorghiade JT Heywood ML McBride PJ Inge MR Mehra CM O'Connor D Reynolds MN Walsh CW Yancy 2010 Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the registry to improve the use of evidence-based heart failure therapies in the outpatient setting (improve hf) Circulation 122 6 585 596 10.1161/CIRCULATIONAHA.109.934471 20660805 10.1161/CIRCULATIONAHA.109.934471
21. GC Fonarow CW Yancy NM Albert AB Curtis WG Stough M Gheorghiade JT Heywood M Mehra CM O'Connor D Reynolds MN Walsh 2007 Improving the use of evidence-based heart failure therapies in the outpatient setting: the improve hf performance improvement registry Am Heart J 154 1 12 38 10.1016/j.ahj.2007.03. 030 17584548 10.1016/j.ahj.2007.03.030 (Pubitemid 46929005)
22. NM Albert GC Fonarow CW Yancy AB Curtis WG Stough M Gheorghiade JT Heywood M McBride MR Mehra CM O'Connor D Reynolds MN Walsh 2010 Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: findings from the registry to improve the use of evidence-based heart failure therapies in the outpatient setting (improve hf) Am Heart J 159 2 238 244 10.1016/j.ahj.2009.11.022 20152222 10.1016/j.ahj.2009.11.022
23. M Komajda P Lapuerta N Hermans JR Gonzalez-Juanatey DJ van Veldhuisen E Erdmann L Tavazzi P Poole-Wilson C Le Pen 2005 Adherence to guidelines is a predictor of outcome in chronic heart failure: the mahler survey Eur Heart J 26 16 1653 1659 10.1093/eurheartj/ehi251 15827061 10.1093/eurheartj/ehi251 (Pubitemid 41389697)
24. F Zannad JJ McMurray H Drexler H Krum DJ van Veldhuisen K Swedberg H Shi J Vincent B Pitt 2010 Rationale and design of the eplerenone in mild patients hospitalization and survival study in heart failure (emphasis-hf) Eur J Heart Fail 12 6 617 622 10.1093/eurjhf/hfq049 20388647 10.1093/eurjhf/hfq049 1:CAS:528:DC%2BC3cXmvVSqsL4%3D